HUM vs LSTA · P/E 39, rev $117.76B vs rev $1.0M
Humana Inc (HUM) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the HUM and LSTA stock pages for the full models.
Not investment advice.